Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients
2006-003567-31Phase 3Active
- Sponsor
- LMU Klinikum
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of telmisartan in hypertension (HTN), sponsored by LMU Klinikum. Primary endpoint: Interleukin-g serum concentration. Started Mar 2007; status: active.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2006-003567-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003567-31.